Dr. Ashfaq A. Marghoob Discusses VECTRA® WB360 at Memorial Sloan Kettering Cancer Center with NBC News
NBC News featured Canfield Scientific's trailblazing VECTRA WB360 whole-body imaging system in action at Memorial Sloan Kettering Cancer Center (MSKCC) on Long Island. This innovative system employs both cross-polarized and non-polarized lighting to generate incredibly detailed 3D images of the entire body in a single capture. Powered by Canfield's state-of-the-art DermaGraphix® software, these images are pivotal in the surveillance of pigmented lesions and rashes.
Dr. Ashfaq A. Marghoob, the director of Memorial Sloan Kettering’s regional skin cancer clinic, highlights the transformative impact of utilizing VECTRA® WB360 with DermaGraphix® software in enhancing early diagnosis and enabling continuous skin monitoring of his patients. The system captures the entire skin surface within one second, as demonstrated with patient Nancy Stove. The powerful system was able to efficiently identify a new suspicious lesion among the 500+ lesions on her body. According to Dr. Marghoob, the WB360 empowers him and his team to expedite detection, thus reducing unnecessary biopsies, and facilitating appropriate treatment planning.
Recent News in In The Media
- ACEMID Launches New Site in Orange, Australia, Featuring VECTRA® WB360 for World's Largest Melanoma Cohort Study
- Advancing Skin Screenings: Dr. Charles E. Mount III and Director Howard Edington, MD Discuss VECTRA® WB360 at AHN Cancer Institute with CBS News
- Dr. Robyn Siperstein, MD, discusses Canfield’s revolutionary AI/AR technology and its role in consultations in MedEsthetics Magazine
- Canfield’s VECTRA® WB360 recently installed at Allegheny Health Network Cancer Institute
Most Recent News
- ACEMID Launches New Site in Orange, Australia, Featuring VECTRA® WB360 for World's Largest Melanoma Cohort Study
- Skin Cancer Awareness Month – Proactiveness and Prevention
- Visit Canfield at The Aesthetic Meeting 2024!
- Advancing Skin Screenings: Dr. Charles E. Mount III and Director Howard Edington, MD Discuss VECTRA® WB360 at AHN Cancer Institute with CBS News